758 related articles for article (PubMed ID: 26157004)
1. Fyn Kinase Regulates Microglial Neuroinflammatory Responses in Cell Culture and Animal Models of Parkinson's Disease.
Panicker N; Saminathan H; Jin H; Neal M; Harischandra DS; Gordon R; Kanthasamy K; Lawana V; Sarkar S; Luo J; Anantharam V; Kanthasamy AG; Kanthasamy A
J Neurosci; 2015 Jul; 35(27):10058-77. PubMed ID: 26157004
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
3. Fyn kinase regulates misfolded α-synuclein uptake and NLRP3 inflammasome activation in microglia.
Panicker N; Sarkar S; Harischandra DS; Neal M; Kam TI; Jin H; Saminathan H; Langley M; Charli A; Samidurai M; Rokad D; Ghaisas S; Pletnikova O; Dawson VL; Dawson TM; Anantharam V; Kanthasamy AG; Kanthasamy A
J Exp Med; 2019 Jun; 216(6):1411-1430. PubMed ID: 31036561
[TBL] [Abstract][Full Text] [Related]
4. Role of the Fyn-PKCδ signaling in SE-induced neuroinflammation and epileptogenesis in experimental models of temporal lobe epilepsy.
Sharma S; Carlson S; Puttachary S; Sarkar S; Showman L; Putra M; Kanthasamy AG; Thippeswamy T
Neurobiol Dis; 2018 Feb; 110():102-121. PubMed ID: 29197620
[TBL] [Abstract][Full Text] [Related]
5. Fyn kinase mediates pro-inflammatory response in a mouse model of endotoxemia: Relevance to translational research.
Saminathan H; Charli A; Luo J; Panicker N; Gordon R; Hostetter JM; Jin H; Anantharam V; Kanthasamy AG; Kanthasamy A
Eur J Pharmacol; 2020 Aug; 881():173259. PubMed ID: 32565338
[TBL] [Abstract][Full Text] [Related]
6. 2-Hydroxy-4-Methylbenzoic Anhydride Inhibits Neuroinflammation in Cellular and Experimental Animal Models of Parkinson's Disease.
Song SY; Kim IS; Koppula S; Park JY; Kim BW; Yoon SH; Choi DK
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33147699
[TBL] [Abstract][Full Text] [Related]
7. Kv1.3 modulates neuroinflammation and neurodegeneration in Parkinson's disease.
Sarkar S; Nguyen HM; Malovic E; Luo J; Langley M; Palanisamy BN; Singh N; Manne S; Neal M; Gabrielle M; Abdalla A; Anantharam P; Rokad D; Panicker N; Singh V; Ay M; Charli A; Harischandra D; Jin LW; Jin H; Rangaraju S; Anantharam V; Wulff H; Kanthasamy AG
J Clin Invest; 2020 Aug; 130(8):4195-4212. PubMed ID: 32597830
[TBL] [Abstract][Full Text] [Related]
8. Proteolytic activation of proapoptotic kinase protein kinase Cδ by tumor necrosis factor α death receptor signaling in dopaminergic neurons during neuroinflammation.
Gordon R; Anantharam V; Kanthasamy AG; Kanthasamy A
J Neuroinflammation; 2012 Apr; 9():82. PubMed ID: 22540228
[TBL] [Abstract][Full Text] [Related]
9. LRRK2 regulates ferroptosis through the system Xc-GSH-GPX4 pathway in the neuroinflammatory mechanism of Parkinson's disease.
Zheng Z; Zhang S; Liu X; Wang X; Xue C; Wu X; Zhang X; Xu X; Liu Z; Yao L; Lu G
J Cell Physiol; 2024 May; 239(5):e31250. PubMed ID: 38477420
[TBL] [Abstract][Full Text] [Related]
10. Naringenin Suppresses Neuroinflammatory Responses Through Inducing Suppressor of Cytokine Signaling 3 Expression.
Wu LH; Lin C; Lin HY; Liu YS; Wu CY; Tsai CF; Chang PC; Yeh WL; Lu DY
Mol Neurobiol; 2016 Mar; 53(2):1080-1091. PubMed ID: 25579382
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Src tyrosine kinase activity by squamosamide derivative FLZ attenuates neuroinflammation in both in vivo and in vitro Parkinson's disease models.
Tai W; Ye X; Bao X; Zhao B; Wang X; Zhang D
Neuropharmacology; 2013 Dec; 75():201-12. PubMed ID: 23916477
[TBL] [Abstract][Full Text] [Related]
12. Mapping and kinetics of microglia/neuron cell-to-cell contacts in the 6-OHDA murine model of Parkinson's disease.
Virgone-Carlotta A; Uhlrich J; Akram MN; Ressnikoff D; Chrétien F; Domenget C; Gherardi R; Despars G; Jurdic P; Honnorat J; Nataf S; Touret M
Glia; 2013 Oct; 61(10):1645-58. PubMed ID: 23893349
[TBL] [Abstract][Full Text] [Related]
13. Isoliquiritigenin inhibits microglia-mediated neuroinflammation in models of Parkinson's disease via JNK/AKT/NFκB signaling pathway.
Bai Y; Zhou J; Zhu H; Tao Y; Wang L; Yang L; Wu H; Huang F; Shi H; Wu X
Phytother Res; 2023 Mar; 37(3):848-859. PubMed ID: 36484427
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of neuroinflammatory responses and behavioral deficits by Ligusticum officinale (Makino) Kitag in stimulated microglia and MPTP-induced mouse model of Parkinson's disease.
Kim BW; Koppula S; Park SY; Kim YS; Park PJ; Lim JH; Kim IS; Choi DK
J Ethnopharmacol; 2015 Apr; 164():388-97. PubMed ID: 25449453
[TBL] [Abstract][Full Text] [Related]
15. The protein-tyrosine phosphatase DEP-1 promotes migration and phagocytic activity of microglial cells in part through negative regulation of fyn tyrosine kinase.
Schneble N; Müller J; Kliche S; Bauer R; Wetzker R; Böhmer FD; Wang ZQ; Müller JP
Glia; 2017 Feb; 65(2):416-428. PubMed ID: 27859601
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-124 regulates the expression of p62/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson's disease.
Yao L; Zhu Z; Wu J; Zhang Y; Zhang H; Sun X; Qian C; Wang B; Xie L; Zhang S; Lu G
FASEB J; 2019 Jul; 33(7):8648-8665. PubMed ID: 30995872
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of Glutaredoxin-1 Activates Microglia and Promotes Neurodegeneration: Implications for Parkinson's Disease.
Gorelenkova Miller O; Behring JB; Siedlak SL; Jiang S; Matsui R; Bachschmid MM; Zhu X; Mieyal JJ
Antioxid Redox Signal; 2016 Dec; 25(18):967-982. PubMed ID: 27224303
[TBL] [Abstract][Full Text] [Related]
18. Microglia-inhibiting activity of Parkinson's disease drug amantadine.
Kim JH; Lee HW; Hwang J; Kim J; Lee MJ; Han HS; Lee WH; Suk K
Neurobiol Aging; 2012 Sep; 33(9):2145-59. PubMed ID: 22035588
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine kinase Fyn regulates iNOS expression in LPS-stimulated astrocytes via modulation of ERK phosphorylation.
Ko HM; Lee SH; Bang M; Kim KC; Jeon SJ; Park YM; Han SH; Kim HY; Lee J; Shin CY
Biochem Biophys Res Commun; 2018 Jan; 495(1):1214-1220. PubMed ID: 29180007
[TBL] [Abstract][Full Text] [Related]
20. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease.
Williams GP; Schonhoff AM; Jurkuvenaite A; Thome AD; Standaert DG; Harms AS
J Neuroinflammation; 2018 Aug; 15(1):244. PubMed ID: 30165873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
